Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:08PM ET
5.25
Dollar change
+1.20
Percentage change
29.63
%
Index- P/E- EPS (ttm)-0.67 Insider Own52.35% Shs Outstand7.83M Perf Week113.41%
Market Cap41.11M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.73M Perf Month104.28%
Income-5.28M PEG- EPS next Q- Inst Own2.49% Short Float0.06% Perf Quarter73.84%
Sales2.09M P/S19.67 EPS this Y- Inst Trans18.58% Short Ratio0.10 Perf Half Y110.84%
Book/sh0.73 P/B7.20 EPS next Y- ROA-55.06% Short Interest0.00M Perf Year81.03%
Cash/sh0.16 P/C32.37 EPS next 5Y- ROE-68.43% 52W Range1.53 - 5.15 Perf YTD126.29%
Dividend Est.- P/FCF- EPS past 5Y-2.00% ROI-67.69% 52W High1.94% Beta0.39
Dividend TTM- Quick Ratio2.54 Sales past 5Y75.66% Gross Margin37.26% 52W Low243.14% ATR (14)0.35
Dividend Ex-Date- Current Ratio2.79 EPS Y/Y TTM7.69% Oper. Margin-235.69% RSI (14)88.99 Volatility15.72% 8.49%
Employees- Debt/Eq0.39 Sales Y/Y TTM2.17% Profit Margin-253.02% Recom1.00 Target Price18.00
Option/ShortNo / Yes LT Debt/Eq0.37 EPS Q/Q-63.06% Payout- Rel Volume21.51 Prev Close4.05
Sales Surprise- EPS Surprise- Sales Q/Q-30.77% Earnings- Avg Volume24.83K Price5.25
SMA20104.90% SMA50102.98% SMA20091.32% Trades Volume232,264 Change29.63%
Mar-27-24 05:50AM
Mar-25-24 07:00AM
Mar-04-24 07:00AM
Jan-29-24 07:00AM
Jan-26-24 07:00AM
09:15AM Loading…
Jan-05-24 09:15AM
Dec-18-23 11:52AM
Nov-28-23 07:00AM
Nov-08-23 07:00AM
Oct-11-23 07:42AM
Sep-20-23 09:15AM
07:30AM
Sep-12-23 07:00AM
Sep-11-23 07:00AM
Aug-30-23 08:00AM
08:30AM Loading…
Jul-27-23 08:30AM
Jul-14-23 09:20AM
Jun-23-23 07:00AM
May-10-23 08:00AM
Apr-29-23 08:13AM
Apr-27-23 08:00AM
Apr-24-23 09:00AM
Apr-19-23 07:00AM
Apr-04-23 07:00AM
Mar-28-23 08:00AM
Mar-08-23 08:00AM
Mar-02-23 08:00AM
Feb-15-23 06:00AM
Jan-24-23 06:00AM
Jan-05-23 06:00AM
06:30AM Loading…
Dec-30-22 06:30AM
Dec-29-22 06:30AM
Dec-14-22 07:00AM
06:00AM
Dec-05-22 07:00AM
Dec-03-22 07:50AM
Dec-02-22 07:00AM
Dec-01-22 07:00AM
Nov-08-22 07:00AM
Oct-27-22 07:00AM
Oct-26-22 07:00AM
Oct-17-22 07:00AM
Oct-04-22 07:00AM
Oct-03-22 08:10AM
07:00AM
Sep-15-22 08:00AM
Sep-08-22 07:00AM
Aug-16-22 06:00AM
Aug-10-22 06:00AM
Aug-01-22 06:00AM
Jul-28-22 08:45AM
Jul-27-22 06:00AM
Jul-26-22 06:00AM
Jul-22-22 07:00AM
Jul-21-22 09:00AM
Jul-15-22 07:00AM
Jun-08-22 01:02PM
Jun-03-22 08:00AM
May-27-22 07:50AM
May-24-22 07:00AM
May-20-22 07:00AM
May-17-22 06:30AM
May-11-22 07:10AM
Apr-29-22 09:00AM
Feb-22-22 07:50AM
Feb-16-22 07:30AM
Feb-04-22 06:00AM
Jan-28-22 07:30AM
Jan-18-22 07:30AM
Jan-10-22 07:30AM
Jan-05-22 07:00AM
Dec-31-21 11:17AM
09:53AM
07:30AM
Dec-29-21 07:30AM
Dec-21-21 08:30AM
Dec-13-21 07:30AM
Dec-03-21 07:30AM
Dec-02-21 06:10AM
Nov-16-21 07:30AM
Nov-10-21 07:30AM
Oct-22-21 07:30AM
Oct-13-21 09:32AM
Oct-12-21 07:30AM
06:32AM
Oct-06-21 08:30AM
Oct-05-21 03:35PM
Oct-04-21 07:30AM
Oct-01-21 12:00PM
Aug-23-21 09:34AM
Jun-15-21 09:17AM
Jan-13-21 08:30AM
Dec-16-20 08:32AM
Dec-15-20 08:31AM
Dec-10-20 08:31AM
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.